Table 1.
Sociodemographic characteristics, risk behaviors, symptoms of sexually transmitted diseases, and number of HR-HPV genotypes detected among female partners at enrollment and follow up, by study arm.
| Enrollment |
Year One |
Year Two |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Intervention (n=226)* | Control (n=214) | p-value | Intervention (n=195) | Control (n=214)** | p-value | Intervention (n=139)*** | Control (n=166)**** | p-value | |
| Age (years) | 0.96 | 0.54 | 0.70 | ||||||
| 15-19 | 36 (15.9%) | 36 (16.8%) | 26 (13.3%) | 30 (14.0%) | 16 (11.5%) | 21 (12.7%) | |||
| 20-24 | 77 (34.1%) | 69 (32.2%) | 62 (31.8%) | 65 (30.4%) | 47 (33.8%) | 46 (27.7%) | |||
| 25-29 | 63 (27.9%) | 58 (27.1%) | 51 (26.2%) | 68 (31.8%) | 47 (33.8%) | 59 (35.5%) | |||
| 30-49 | 50 (22.1%) | 51 (23.8%) | 56 (28.7%) | 51 (23.8%) | 29 (20.9%) | 40 (24.1%) | |||
| Education | 0.70 | 0.39 | |||||||
| No education | 25 (11.1%) | 33 (15.4%) | 0.18 | 29 (14.9%) | 29 (13.6%) | 17 (12.2%) | 26 (15.7%) | ||
| Primary or Secondary | 201 (88.9%) | 181 (84.6%) | 166 (85.1%) | 185 (86.4%) | 122 (87.8%) | 140 (84.3%) | |||
| Number of sexual partners past year | 0.52 | 0.85 | |||||||
| 1 | 213 (94.2%) | 203 (94.9%) | 0.78 | 182 (93.3%) | 202 (94.8%) | 126 (92.6%) | 151 (92.1%) | ||
| 2+ | 13 (5.8%) | 11 (5.1%) | 13 (6.7%) | 11 (5.2%) | 10 (7.4%) | 13 (7.9%) | |||
| Condom use in past year | 0.09 | 0.13 | |||||||
| None | 186 (82.7%) | 169 (79.0%) | 0.26 | 151 (77.4%) | 168 (78.5%) | 107 (78.7%) | 119 (72.6%) | ||
| Inconsistent use | 39 (17.3%) | 43 (20.1%) | 43 (22.1%) | 39 (18.2%) | 29 (21.3%) | 41 (25.0%) | |||
| Consistent condom use | 0 (0.0%) | 2 (0.9%) | 1 (0.5%) | 7 (3.3%) | 0 (0.0%) | 4 (2.4%) | |||
| Self-reported symptoms of STDs in past year | |||||||||
| Genital ulcer disease | 36 (15.9%) | 32 (15.0%) | 0.78 | 23 (11.8%) | 34 (16.0%) | 0.23 | 16 (11.7%) | 35 (21.2%) | 0.03 |
| Vaginal discharge | 107 (47.3%) | 114 (53.3%) | 0.21 | 81 (41.5%) | 93 (43.7%) | 0.67 | 47 (34.3%) | 69 (41.8%) | 0.24 |
| Dysuria | 45 (19.9%) | 50 (23.4%) | 0.38 | 26 (13.3%) | 28 (13.1%) | 0.96 | 25 (18.2%) | 37 (22.4%) | 0.37 |
| HR-HPV Genotypes | |||||||||
| 1 | 154 (68.1%) | 129 (60.3%) | 0.05 | 126 (64.6%) | 131 (61.2%) | 0.50 | 81 (58.3%) | 90 (54.2%) | 0.61 |
| 2 | 40 (17.7%) | 59 (27.6%) | 38 (19.5%) | 52 (24.3%) | 40 (28.8%) | 48 (28.9%) | |||
| 3+ | 32 (14.2%) | 26 (12.2%) | 31 (15.9%) | 31 (14.5%) | 18 (12.9%) | 28 (16.9%) | |||
*
One woman did not report any information on condom use.
**
One woman did not report any information on number of sexual partners or symptoms of STDs.
***
Three women did not report any information on condom use and number of sexual partners and two women did not report any information on symptoms of STDs.
****
Two women did not report any information on condom use and and number of sexual partners and one woman did not report any information on symptoms of STDs.